Skip to main content
Toggle navigation
Login
Home
Back
Favorite
Like
Facebook
Tweet
Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Chemotherapy
Wednesday, August 2, 2023
9:30 AM – 9:45 AM
ET
Presenter(s)
Anup Kasi, MD, MPH
Kansas University Cancer Center